Acasti Pharma Rebrands As Grace Therapeutics, Inc.; Will Trade Under "GRCE" On Nasdaq Starting October 28, 2024
Portfolio Pulse from Benzinga Newsdesk
Acasti Pharma has rebranded as Grace Therapeutics, Inc. and will begin trading under the new ticker symbol 'GRCE' on Nasdaq starting October 28, 2024. A virtual key opinion leader event is scheduled for November 20.
October 25, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Acasti Pharma is rebranding to Grace Therapeutics, Inc. and will change its Nasdaq ticker to 'GRCE' on October 28, 2024.
The rebranding and ticker change are significant corporate actions that may affect investor perception and stock liquidity. However, these changes do not directly impact the company's financial performance, leading to a neutral short-term price impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100